These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10231841)

  • 1. Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells.
    Kleeff J; Wildi S; Friess H; Korc M
    Pancreas; 1999 May; 18(4):364-70. PubMed ID: 10231841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition.
    Baldwin RL; Friess H; Yokoyama M; Lopez ME; Kobrin MS; Büchler MW; Korc M
    Int J Cancer; 1996 Jul; 67(2):283-8. PubMed ID: 8760600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.
    Wagner M; Kleeff J; Lopez ME; Bockman I; Massaqué J; Korc M
    Int J Cancer; 1998 Oct; 78(2):255-60. PubMed ID: 9754660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
    Hu W; Wu W; Nash MA; Freedman RS; Kavanagh JJ; Verschraegen CF
    Anticancer Res; 2000; 20(2A):729-33. PubMed ID: 10810347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.
    Villanueva A; García C; Paules AB; Vicente M; Megías M; Reyes G; de Villalonga P; Agell N; Lluís F; Bachs O; Capellá G
    Oncogene; 1998 Oct; 17(15):1969-78. PubMed ID: 9788440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
    Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
    Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest.
    Nicolás FJ; Hill CS
    Oncogene; 2003 Jun; 22(24):3698-711. PubMed ID: 12802277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
    Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
    Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
    Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta.
    Kang SH; Won K; Chung HW; Jong HS; Song YS; Kim SJ; Bang YJ; Kim NK
    Int J Cancer; 1998 Aug; 77(4):620-5. PubMed ID: 9679767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
    Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
    Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and expression of betaig-h3 in pancreatic cancer cells.
    Schneider D; Kleeff J; Berberat PO; Zhu Z; Korc M; Friess H; Büchler MW
    Biochim Biophys Acta; 2002 Oct; 1588(1):1-6. PubMed ID: 12379307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.
    Feng XH; Filvaroff EH; Derynck R
    J Biol Chem; 1995 Oct; 270(41):24237-45. PubMed ID: 7592630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells.
    Kleeff J; Korc M
    J Biol Chem; 1998 Mar; 273(13):7495-500. PubMed ID: 9516449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.